448 related articles for article (PubMed ID: 8452322)
61. Effect of low-dose ramipril on microalbuminuria in normotensive or mild hypertensive non-insulin-dependent diabetic patients. North-East Italy Microalbuminuria Study Group.
Trevisan R; Tiengo A
Am J Hypertens; 1995 Sep; 8(9):876-83. PubMed ID: 8541002
[TBL] [Abstract][Full Text] [Related]
62. Effects of short-term glycemic control, low protein diet and administration of enalapril on renal hemodynamics and protein permselectivity in type 2 diabetic patients with microalbuminuria.
Narita T; Koshimura J; Suzuki K; Murata M; Meguro H; Fujita H; Kitazato H; Ito S
Tohoku J Exp Med; 1999 Oct; 189(2):117-33. PubMed ID: 10775055
[TBL] [Abstract][Full Text] [Related]
63. Spironolactone in type 2 diabetic nephropathy: Effects on proteinuria, blood pressure and renal function.
van den Meiracker AH; Baggen RG; Pauli S; Lindemans A; Vulto AG; Poldermans D; Boomsma F
J Hypertens; 2006 Nov; 24(11):2285-92. PubMed ID: 17053552
[TBL] [Abstract][Full Text] [Related]
64. Effect of an alpha-adrenergic blocker, and ACE inhibitor and hydrochlorothiazide on blood pressure and on renal function in type 2 diabetic patients with hypertension and albuminuria. A randomized cross-over study.
Rachmani R; Levi Z; Slavachevsky I; Half-Onn E; Ravid M
Nephron; 1998 Oct; 80(2):175-82. PubMed ID: 9736816
[TBL] [Abstract][Full Text] [Related]
65. Tocotrienol-Rich Vitamin E from Palm Oil (Tocovid) and Its Effects in Diabetes and Diabetic Nephropathy: A Pilot Phase II Clinical Trial.
Tan SMQ; Chiew Y; Ahmad B; Kadir KA
Nutrients; 2018 Sep; 10(9):. PubMed ID: 30227659
[TBL] [Abstract][Full Text] [Related]
66. The telmisartan renoprotective study from incipient nephropathy to overt nephropathy--rationale, study design, treatment plan and baseline characteristics of the incipient to overt: angiotensin II receptor blocker, telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) Study.
Makino H; Haneda M; Babazono T; Moriya T; Ito S; Iwamoto Y; Kawamori R; Takeuchi M; Katayama S
J Int Med Res; 2005; 33(6):677-86. PubMed ID: 16372586
[TBL] [Abstract][Full Text] [Related]
67. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group.
BMJ; 1991 Jan; 302(6770):210-6. PubMed ID: 1998761
[TBL] [Abstract][Full Text] [Related]
68. Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes.
Estacio RO; Coll JR; Tran ZV; Schrier RW
Am J Hypertens; 2006 Dec; 19(12):1241-8. PubMed ID: 17161769
[TBL] [Abstract][Full Text] [Related]
69. Long-term effect of a chicken-based diet versus enalapril on albuminuria in type 2 diabetic patients with microalbuminuria.
de Mello VD; Zelmanovitz T; Azevedo MJ; de Paula TP; Gross JL
J Ren Nutr; 2008 Sep; 18(5):440-7. PubMed ID: 18721739
[TBL] [Abstract][Full Text] [Related]
70. Comparative effects of enalapril, atenolol and chlorthalidone on blood pressure and kidney function of diabetic patients affected by arterial hypertension and persistent proteinuria.
Stornello M; Valvo EV; Scapellato L
Nephron; 1991; 58(1):52-7. PubMed ID: 1857482
[TBL] [Abstract][Full Text] [Related]
71. Effect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIER.
Mogensen CE; Viberti G; Halimi S; Ritz E; Ruilope L; Jermendy G; Widimsky J; Sareli P; Taton J; Rull J; Erdogan G; De Leeuw PW; Ribeiro A; Sanchez R; Mechmeche R; Nolan J; Sirotiakova J; Hamani A; Scheen A; Hess B; Luger A; Thomas SM;
Hypertension; 2003 May; 41(5):1063-71. PubMed ID: 12654706
[TBL] [Abstract][Full Text] [Related]
72. Dual blockade of the renin-angiotensin system in diabetic nephropathy: a randomized double-blind crossover study.
Rossing K; Christensen PK; Jensen BR; Parving HH
Diabetes Care; 2002 Jan; 25(1):95-100. PubMed ID: 11772908
[TBL] [Abstract][Full Text] [Related]
73. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.
Estacio RO; Jeffers BW; Gifford N; Schrier RW
Diabetes Care; 2000 Apr; 23 Suppl 2():B54-64. PubMed ID: 10860192
[TBL] [Abstract][Full Text] [Related]
74. Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.
Nielsen FS; Rossing P; Gall MA; Skøtt P; Smidt UM; Parving HH
Diabetes; 1997 Jul; 46(7):1182-8. PubMed ID: 9200654
[TBL] [Abstract][Full Text] [Related]
75. Microalbuminuria reduction with telmisartan in normotensive and hypertensive Japanese patients with type 2 diabetes: a post-hoc analysis of The Incipient to Overt: Angiotensin II Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) study.
Makino H; Haneda M; Babazono T; Moriya T; Ito S; Iwamoto Y; Kawamori R; Takeuchi M; Katayama S;
Hypertens Res; 2008 Apr; 31(4):657-64. PubMed ID: 18633177
[TBL] [Abstract][Full Text] [Related]
76. Albuminuria induced by exercise in hypertensive type I and type II diabetic patients: a randomised, double-blind study on the effects of acute administration of captopril and nifedipine.
Romanelli G; Giustina A; Cravarezza P; Caldonazzo A; Agabiti-Rosei E; Giustina G
J Hum Hypertens; 1991 Jun; 5(3):167-73. PubMed ID: 1920340
[TBL] [Abstract][Full Text] [Related]
77. Losartan reduces albuminuria in patients with essential hypertension. An enalapril controlled 3 months study.
Nielsen S; Dollerup J; Nielsen B; Jensen HA; Mogensen CE
Nephrol Dial Transplant; 1997; 12 Suppl 2():19-23. PubMed ID: 9269694
[TBL] [Abstract][Full Text] [Related]
78. Contrasting effects of angiotensin converting inhibitor and alpha-1-antagonist on albuminuria in insulin-dependent diabetes mellitus patients with nephropathy.
Holdaas H; Hartmann A; Berg KJ; Langberg H; Blystad L; Fauchald P
J Intern Med; 1995 Jan; 237(1):63-71. PubMed ID: 7830033
[TBL] [Abstract][Full Text] [Related]
79. Dual blockade of the renin-angiotensin-aldosterone system is safe and effective in reducing albuminuria in Asian type 2 diabetic patients with nephropathy.
Tan F; Mukherjee JJ; Lee KO; Lim P; Liew CF
Singapore Med J; 2010 Feb; 51(2):151-6. PubMed ID: 20358155
[TBL] [Abstract][Full Text] [Related]
80. Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study).
Marre M; Lievre M; Chatellier G; Mann JF; Passa P; Ménard J;
BMJ; 2004 Feb; 328(7438):495. PubMed ID: 14960504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
